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Abstract Interstitial lung disease (ILD) is a hallmark of
systemic sclerosis (SSc). Although high-resolution com-
puted tomography (HRCT) is the gold standard to diagnose
ILD, recently lung ultrasound (LUS) has emerged in SSc
patients as a new promising technique for the ILD evalu-
ation, noninvasive and radiation-free. The aim of this study
was to evaluate if there is a correlation between LUS, chest
HRCT, pulmonary function tests findings and clinical
variables of the disease. Thirty-nine patients (33 women
and 6 men; mean age 51 ± 15.2 years) underwent clinical
examination, HRCT, pulmonary function tests and LUS for
detection of B-lines. A positive correlation exists between
the number of B-lines and the HRCT score (r = 0.81,
p\ 0.0001), conversely a negative correlation exists
between the number of B-lines and diffusing capacity of
the lung for carbon monoxide (DLCO) (r = -0.63,
p\ 0.0001). The number of B-lines increases along with
the progression of the capillaroscopic damage. A statisti-
cally significant difference in the number of B-lines was
found between patients with and without digital ulcers [42
(3–84) vs 16 (4–55)]. We found that the number of B-lines
increased with the progression of both HRCT score and
digital vascular damage. LUS may therefore, be a useful
tool to determine the best timing for HRCT execution, thus,
preventing for many patients a continuous and useless
exposure to ionizing radiation.
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Introduction
Interstitial lung disease (ILD) is a hallmark in the course of
systemic sclerosis (SSc) and pulmonary fibrosis represents
one of the main causes of morbidity and mortality [1].
High-resolution computed tomography (HRCT) is the gold
standard for the diagnosis of ILD, and correlates with
pulmonary function tests abnormalities [2, 3]. Recently,
lung ultrasound (LUS) has emerged in SSc patients as a
new promising technique for the evaluation of different
pulmonary abnormalities, noninvasive and radiation-free.
ILD can be suggested by the presence of B-lines (also
called US lung comets) in LUS examination. B-lines
originate from thickened interlobular septa, and are a
sonographic sign of interstitial disease [4].
The aim of this study was to evaluate if there is a cor-
relation between LUS, chest HRCT and pulmonary func-
tion tests findings. We also evaluated the correlation
between LUS findings and the clinical variables of the
disease: subset and duration of disease, modified Rodnan
skin score (mRSS), disease activity index, disease severity
score, digital ulcers history and capillaroscopic pattern.
Materials and methods
Thirty-nine patients (33 women and 6 men; mean age
51 ± 15.2 years) fulfilling the American College of
Rheumatology/European League Against Rheumatism
Collaborative Initiative criteria for classification and
diagnosis of SSc, were enrolled in this study from
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November 2014 to April 2015 [5]. Fifteen patients had
limited cutaneous SSc (lcSSc) and 24 presented diffuse
cutaneous SSc (dcSSc) as defined by Le Roy et al. [6].
Table 1 shows the SSc patients’ epidemiological and
clinical features.
All SSc patients who had a need to undergo HRCT for
staging or follow-up were enrolled. LUS examination for
specific assessment of B-lines was performed within
4 weeks of the chest HRCT scan.
Patients with cardiac failure or valve diseases, idiopathic
pulmonary fibrosis, venous occlusive disease (PVOD),
chronic obstructive pulmonary diseases (COPD) were
excluded. Smokers were also excluded.
The subjects’ written consent was obtained according to
the Declaration of Helsinki and the study has been
approved by the ethics committee of Sapienza University.
Lung ultrasound (LUS)
LUS was performed by a Toshiba’s Ultrasound System
(Tokyo, Japan) equipped with a convex 2.5- to 3.5-MHz
probe. Although there is no clear consensus about lung
ultrasound methodology, we used the methodology applied
in previous studies of SSc patients.
We analyzed the anterior and lateral hemithoraces,
scanning along the parasternal, midclavicular, anterior
axillary, and midaxillary lines, to evaluate location and
number of B-lines. A B-line was defined as a discrete laser-
like vertical hyperechoic reverberation artifact that arises
from the pleural line extending to the bottom of the screen
without fading, moving synchronously with lung sliding.
The number of B-lines was recorded for each intercostal
space. The sum of B-lines yielded a score suggestive for
the extent of ILD. A scan was considered positive either
when C3 B-lines were present in at least two adjacent
scanning sites or when a total of[5 B-lines were recorded.
A score of zero was defined as a complete absence of
B-lines in all scanning sites. A full white screen in a single
scanning site was scored as corresponding to 10 B-lines [7,
8]. One observer acquired and analyzed all chest sonog-
raphy studies. The intra-observer variability in B-line
assessment was 3.8 %.
Chest HRCT
All HRCT examinations were performed according to
standard protocol using a CT 64GE light Speed VCT power
scanner with a rotation tube scanning time of 0.65 s. Scans
were obtained at full inspiration from the apex to the lung
base with patients in supine position, at 120 kV and
300 mA s, and slice thickness and scans spacing of 1.25 and
7 mm, respectively. HRCT examination did not include the
use of contrast media agents. Parenchymal abnormalities on
HRCT were coded and scored in all the images by inde-
pendent readers, blinded with respect to LUS results,
according to the score elaborated by Warrick et al. This
score includes a ‘severity score’, ranging from 0 (normal) to
15 (all lesions present), and an ‘extension score’, ranging
from 0 (normal) to 15 (more than nine pulmonary segments
involved). A total Warrick score was obtained by summing
the severity and the extension scores [9].
Baseline pulmonary function tests (PFT)
Spirometric parameters of flows and volumes [(FEV1,
forced expiratory volume in the 1st second), FVC (forced
vital capacity), FEV1/FVC)] and single-breath carbon
monoxide (CO) diffusing capacity (DLCO), corrected for
hemoglobin concentration, were recorded with a Quark
PFT 2 spirometer (Cosmed) and expressed according to the
standards recommended by the American/European Res-
piratory Society [10]. All spirometric parameters are
expressed as percentage of predicted.
Nailfold videocapillaroscopy
Nailfold videocapillaroscopy (NVC) was performed by an
optical probe, equipped with magnification 2009 contact
lens and connected to an image analysis software (Pinnacle
Studio Version 8). The identified patterns were classified as
early, active or late [11].
Skin thickening, disease activity and disease severity
Skin thickening was assessed by a mRSS, which is the
most used method to assess skin induration in SSc. It is
Table 1 Epidemiological and clinical features of 39 patients with
systemic sclerosis
Gender (female/male) 33/6
Age, years 51 ± 15.2
Disease duration, years 8.5 ± 6.3
DAI 2.4 ± 1.5
DSS 6.5 ± 3.7
dcSSc/lcSSc 24/15
SSc-specific autoantibodies, n (%)
Anti-topoisomerase I 23 (59)
Anticentromere 10 (25.6)
None 6 (15.4)




DAI disease activity score, DSS disease severity scale, lcSSc limited
cutaneous SSc, dcSSc diffuse cutaneous SSc
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determined at a standardized location of 17 different sites
of the body through a standardized pinching method, with a
score ranging from 0 to 3 [12].
Disease activity and disease severity were measured
using European Scleroderma Study Group activity index
(DAI) [13] and Medsger scleroderma disease severity scale
(DSS) [14], respectively.
Statistical analysis
The results were expressed as mean and standard deviation
(SD) or median and range, as appropriate. Commercial soft-
ware (SPSS version 22.0) was used for statistical analysis.
The coefficient of skewness and the coefficient of kurtosis
were used to evaluate the normal distribution of data.Multiple
regression analysis was applied to evaluate the relationship
between the number of B-lines and the demographic and
clinical features (age, duration of disease, mRSS, DAI, DSS).
Pearson product-moment correlation coefficient (r) was used
to test for an association between numerical variables. Group
comparisons were made by Student’s unpaired two-tailed
t test or the Kruskal–Wallis test, as appropriate. p values
\0.05 were considered significant.
Results
The mean number of B-lines are 29.1 ± 21.8 and the mean
HRCT score is 9.5 ± 6.4. PFTs mean values are: DLCO
73.6 ± 16.5, FVC 101.7 ± 18, FEV1 98.6 ± 16.
A positive correlation exists between the number of
B-lines and HRCT score (r = 0.81, p\ 0.0001), con-
versely there is a negative correlation between the B-lines
score, DLCO (r = -0.63, p\ 0.0001) and FVC
(r = -0.48, p\ 0.001). No significant correlations are
found between FEV1 and B-lines number (r = -0.29,
p[ 0.05) (Fig. 1).
In the multiple regression analysis of clinical variables
of disease (duration of disease, mRSS, DAI, DSS with age
as covariate) only DSS demonstrates a significant correla-
tion with the number of B-lines (r = 0.80, p\ 0.01)
(Fig. 2). No significant (p[ 0.05) correlation is observed
with age, disease duration, mRSS, PAPs and DAI. B-lines
score are significantly (p\ 0.05) higher in dcSSc patients
than in lcSSc patients [25 (8–84) vs 15 (3–52].
Fig. 1 Correlation between number of B-lines (mean and standard
deviation) and high-resolution computed tomography (HRTC) score
and carbon monoxide diffusing capacity (DLCO) in 39 patients
systemic sclerosis patients. The HRTC score was calculated by total
Warrick score (mean and standard deviation), the DLCO was
expressed as percentage of predicted
Fig. 2 Correlation between number of B-lines (mean and standard
deviation) and disease severity scale (DSS) in 39 patients systemic
sclerosis patients. DSS (mean and standard deviation) was calculated
by Medsger scleroderma disease severity scale
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The NVC showed an early capillaroscopic pattern in 12
(30.8 %) SSc patients, an active capillaroscopic pattern in
12 (30.8 %) SSc patients and a late capillaroscopic pattern
in 15 38.5 %) SSc patients. B-lines scores are significantly
(p\ 0.01) different in the three capillaroscopic groups:
early 11.7 (3–29), active 31.1 (10–55), late 41.5 (4–84)
(Fig. 3).
Seventeen (43 %) SSc patients have a digital ulcer
history and 22 (57 %) SSc patients have no digital ulcer
history. In SSc patients with a history of digital ulcer, s the
median B-lines score is significantly (p\ 0.01) higher than
in SSc patients with no digital ulcers history [42 (3–84) vs
16 (4–55)].
Discussion
Our results confirm that LUS is a very sensitive technique
for the evaluation of ILD in SSc patients. The presence of
B-lines at LUS examination correlates with HRCT score
and DLCO decrease. In particular, we found a positive
correlation between B-line numbers and HRCT score,
while the number of B-lines negatively correlates with
PFTs. LUS has already been used to assess the extent of
pulmonary fibrosis in SSc patients. Gargani et al. observed
the presence of ultrasound lung comets in about 51 % of
SSc patients, and find a significant positive linear correla-
tion between ultrasound lung comets and Warrick scores.
The authors conclude that ultrasound lung comets are often
present in SSc, more frequently in the diffuse than in the
limited form, and that they correlate reasonably well with
the HRCT-derived assessment of lung fibrosis [15]. They
represent a simple, bedside, radiation-free hallmark of
pulmonary fibrosis, with a great potential diagnostic and
prognostic value. Barskova et al. studied 58 consecutive
patients with SSc, finding a significant difference in the
number of B-lines between patients with and without ILD
at HRCT, with a concordance rate of 83 %. Moreover, the
authors demonstrate that LUS is a sensitive technique for
the evaluation of ILD even in patients with a pretty recent
diagnosis of SSc and ILD, finding a positive correlation
between B-lines numbers and HRCT score [16]. Other
authors evaluated LUS role in other forms of ILD,
including primary pulmonary fibrosis and sarcoidosis.
Sperandeo et al. in a heterogeneous group of patients with
ILD demonstrate that transthoracic ultrasound may docu-
ment early and late-stage changes associated with the dis-
ease [17].
To our knowledge we are the first to postulate that
B-lines score positively correlates with DSS and digital
vascular damage, evaluated by NVC. The number of
B-lines increases with the progression of capillaroscopic
damage. In addition, the number of B-lines is significantly
higher in SSc patients with DU than in SSc patients without
DU. Therefore, we can assume that the number of B-lines
increases with the progression of both HRCT score and
digital vascular damage. For the first time in this study we
demonstrate that in 39 SSc patients the number of B-lines
correlates with capillaroscopic and digital vascular dam-
age. Many of the severe internal organ complications of
SSc are vascular. Intimal hyperplasia, endothelial dys-
function and occlusive vasculopathy are ubiquitous fea-
tures of SSc. These vascular lesions are the underlying
basis of important clinical syndromes in SSc, including
Fig. 3 Number of B-lines (median and range) in 39 patients systemic
sclerosis patients grouped by capillaroscopic pattern or digital ulcers
history. The left box shows the number of B-lines in 12 SSc patients
with early pattern, in 12 with active pattern and 15 with late pattern.
The right box shows the number of B-lines in 17 (43 %) SSc patients
with digital ulcers history and in 22 (57 %) SSc patients without
digital ulcers history
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Raynaud’s phenomenon, digital ulcers, pulmonary arterial
hypertension, erectile dysfunction, gastrointestinal com-
plication and renal damage [18]. We propose that vascular
damage plays a key role in the pathogenesis of B-lines.
Ultrasound plays a crucial role in the assessment of
organ involvement in SSc, and LUS could be an option in
association with PFTs for the follow-up of ILD in SSc
patients. An important limitation for the use of this tech-
nique is that B-lines score lacks specificity, since B-lines
can be present in an array of conditions, not only SSc-
related ILD. Moreover, in obese patients, or patients with a
high thoracic impedance ultrasound is quite difficult to
perform.
Future studies could improve the diagnostic detection of
LUS using an anterior scanning of the thorax. Nevertheless,
although HRCT is the gold standard for the evaluation of
ILD, LUS might become a useful tool for guiding the use
and timing of HRCT, avoiding for SSc patients a contin-
uous and useless exposure to ionizing radiation.
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